НовостиBenzingaRBC Capital Maintains Outperform on Apotex Health, Raises Price Target to C$46 RBC Capital Maintains Outperform on Apotex Health, Raises Price Target to C$46 Benzinga 2026.11.13 15:34 (GMT+0) Открыть на Benzinga Другие новости